Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effect of PERMEAPROTECT on the Quality of Life of Patients With Fibromyalgia (L2009-03)

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by Lescuyer Laboratory
Sponsor:
Collaborator:
Hospices Civils de Lyon
Information provided by (Responsible Party):
Lescuyer Laboratory
ClinicalTrials.gov Identifier:
NCT01469936
First received: October 28, 2011
Last updated: March 17, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2015
  Estimated Primary Completion Date: April 2015 (Final data collection date for primary outcome measure)